BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 13296803)

  • 1. [On BAL treatment of hepatolenticular degeneration].
    KNUPPEL H
    Med Klin; 1956 Jan; 51(3):107-8. PubMed ID: 13296803
    [No Abstract]   [Full Text] [Related]  

  • 2. [Biochemistry of hepatolenticular degeneration; its treatment with BAL].
    BONDUELLE M; HARL JM
    Bull Med; 1953 Jun; 67(12):333-5. PubMed ID: 13082329
    [No Abstract]   [Full Text] [Related]  

  • 3. DIMERCAPROL for hepatolenticular degeneration.
    Lancet; 1952 Jan; 1(6700):199-200. PubMed ID: 14889814
    [No Abstract]   [Full Text] [Related]  

  • 4. [Case of hepatolenticular degeneration treated by BAL].
    DRABKOWSKA AM
    Neurol Neurochir Psychiatr Pol; 1956; 6(5):541-7. PubMed ID: 13407808
    [No Abstract]   [Full Text] [Related]  

  • 5. Hepatolenticular degeneration; review of the literature and report of a case with dimercaprol (BAL) therapy.
    SCHECHTER MM; JONES CA
    AMA Arch Intern Med; 1953 Apr; 91(4):541-9. PubMed ID: 13039608
    [No Abstract]   [Full Text] [Related]  

  • 6. [BAL (2, 3-dimercaptopropanol) therapy of hepatolenticular degeneration].
    BOZHINOV S
    Suvr Med (Sofiia); 1955; 6(7):96-100. PubMed ID: 13299060
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of dimercaprol (BAL) in hepatolenticular degeneration; report of a case, with clinical and electroencephalographic study.
    STREIFLER M; FELDMAN S
    AMA Arch Neurol Psychiatry; 1953 Jan; 69(1):84-90. PubMed ID: 12996137
    [No Abstract]   [Full Text] [Related]  

  • 8. The effect of BAL (2,3-dimercaptopropanol) on hepatolenticular degeneration (Wilson's disease).
    DENNY-BROWN D; PORTER H
    Trans Am Neurol Assoc; 1951; 56():79-84. PubMed ID: 14913592
    [No Abstract]   [Full Text] [Related]  

  • 9. The effect of BAL (2,3-dimercaptopropanol) on hepatolenticular degeneration (Wilson's disease).
    DENNY-BROWN D; PORTER H
    N Engl J Med; 1951 Dec; 245(24):917-25. PubMed ID: 14882450
    [No Abstract]   [Full Text] [Related]  

  • 10. Hepatolenticular degeneration; follow-up report of a case treated with dimercaprol (BAL), potassium sulfide, and high-protein diet.
    FERRISS GS; BERRY S
    AMA Arch Intern Med; 1957 Apr; 99(4):656-9. PubMed ID: 13410170
    [No Abstract]   [Full Text] [Related]  

  • 11. Tissue copper determinations in a case of hepatolenticular degeneration treated with BAL (dimercaprol).
    PALMER JF; DREW AL; CHENOWETH MB
    Med Bull (Ann Arbor); 1953 Nov; 19(11):308-11. PubMed ID: 13122933
    [No Abstract]   [Full Text] [Related]  

  • 12. [BAL therapy of hepatolenticular degeneration].
    CAROIT M
    Sem Hop; 1955 May; 31(28):1625-6. PubMed ID: 14385888
    [No Abstract]   [Full Text] [Related]  

  • 13. [BAL therapy and copper excretion in hepatolenticular syndrome].
    ERDMANN-MULLER GJ; HORNBOSTEL H
    Klin Wochenschr; 1953 Dec; 31(45-46):1102-3. PubMed ID: 13118699
    [No Abstract]   [Full Text] [Related]  

  • 14. Hepatolenticular degeneration; clinical and pathological report of a case treated with BAL.
    RASKIN N; MACKENZIE JM
    J Nerv Ment Dis; 1954; 120(3-4):176-83. PubMed ID: 13233959
    [No Abstract]   [Full Text] [Related]  

  • 15. Dimercaprol in the pre-neurological stage of Wilson's disease (hepatolenticular degeneration).
    WARNOCK CG; NEILL DW
    J Neurol Neurosurg Psychiatry; 1954 Feb; 17(1):70-4. PubMed ID: 13131080
    [No Abstract]   [Full Text] [Related]  

  • 16. [Results of BAL therapy of hepatolenticular degeneration].
    WENDER M
    Pol Tyg Lek; 1959 Jun; 14():1107-9. PubMed ID: 13843954
    [No Abstract]   [Full Text] [Related]  

  • 17. [Side-effects in BAL therapy of hepatolenticular degeneration (Westphal-Strumpell-Wilson)].
    MUELLER K
    Arztl Wochensch; 1960 Jan; 15():76-8. PubMed ID: 14424958
    [No Abstract]   [Full Text] [Related]  

  • 18. Penicillamine, a new oral therapy for Wilson's disease.
    WALSHE JM
    Am J Med; 1956 Oct; 21(4):487-95. PubMed ID: 13362281
    [No Abstract]   [Full Text] [Related]  

  • 19. [New concepts of pathogenesis of hepatolenticular degeneration; attempt of BAL therapy; first report].
    OSETOWSKA-WIECKOWSKA E
    Pol Tyg Lek (Wars); 1955 Mar; 10(13):410-5. PubMed ID: 14384604
    [No Abstract]   [Full Text] [Related]  

  • 20. [Results of the treatment of hepatolenticular degeneration with small doses of BAL, potassium sulfide and protein-rich diets].
    WENDER M
    Pol Tyg Lek; 1961 Jun; 16():884-7. PubMed ID: 13784343
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.